SQZ Biotechnologies Co. (SQZ) Social Stream
SQZ Biotechnologies Co (SQZ) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SQZ.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 47 weeks, SQZ's average price target has gone down $2.08.
Over the past 47 weeks, SQZ's average upside potential has been 93.63%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SQZ Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- SQZ has a higher upside potential (average analyst target price relative to current price) than 89.48% of all US stocks.
- The average analyst price target of SQZ is greater than 75.79% of stocks in the small market cap category.
- SQZ has a less variance in analysts' estimates than 27.94% of stocks in the small market cap category.
- SQZ Biotechnologies Co's number of analysts covering the stock is greater than 71.36% of stocks in the small market cap category.
In the Pharmaceutical Products industry, ACET, TARS and CMRX are the three stocks most similar to SQZ Biotechnologies Co regarding the price target and analyst recommendation information presented here.
Is SQZ a Buy, Hold or Sell? See the POWR Ratings now!